Olivier Meyer Ph.D

Olivier Meyer Ph.D General Information

Biography

Dr. Olivier Meyer co-founded and served as Chairman of the Board, President and Chief Executive Officer at Carlina Technologies. He had a scientific background by training. He obtained his Ph.D. in pharmaceutical sciences from the University of Paris-Sud, France, in 1995. The same year, Dr. Meyer joined the Cancer Research Institute of the University of California at San Francisco, as a post-doctoral fellow in the laboratory of Pr. Demetrios Papahadjopoulos who was one of the co-inventor of the pioneered anticancer nanomedicine product Doxil®/Caelyx™. During this period, Olivier Meyer had developed a number of innovative lipid-based systems for the delivery of anti-cancer drugs, contrast agents and therapeutic biologics. During his more than 20 years of professional experience, Olivier Meyer occupied various R&D and corporate top management positions in biotechnology companies and the pharmaceutical industry both in France and Canada. Olivier Meyer has been awarded by the French Ministry of Research in 2010 for the creation and the development of innovative technology companies and co-founded CARLINA Technologies the same year.